Evidence map›Paper›PMID 40656425›Full record

ArticleCureus2025

Absence of KRAS Mutation as an Indicator of Pancreatic Metastasis Originating From Lung Cancer: A Case Report.

Shuhei Suzuki, Soshi Oyama, Takanobu Kabasawa, Hidenori Sato, Hidekazu Matsumoto

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shuhei SuzukiDepartment of Internal Medicine, Yamagata Prefectural Shinjo Hospital, Yamagata, JPN.
Soshi OyamaDepartment of Internal Medicine, Yamagata Prefectural Shinjo Hospital, Yamagata, JPN.
Takanobu KabasawaDepartment of Pathology, Yamagata University, Yamagata, JPN.
Hidenori SatoDepartment of Surgery, Yamagata University, Yamagata, JPN.
Hidekazu MatsumotoDepartment of Surgery, Yamagata Prefectural Shinjo Hospital, Yamagata, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Differentiating between primary pancreatic adenocarcinoma with pulmonary metastasis and primary lung adenocarcinoma with pancreatic metastasis presents a significant diagnostic challenge due to histological similarities. This distinction is crucial as it directly impacts treatment strategies and patient outcomes. We present a case of a 74-year-old female with concurrent pancreatic and pulmonary masses discovered during a routine health screening. Initial evaluations suggested primary pancreatic cancer with pulmonary metastasis based on imaging characteristics. However, molecular analysis revealed the absence of

Indexed as

cancer genomicsegfr mutationskras mutationnon-small cell lung cancerpancreas tumor

Identifiers

PMID40656425
PMCPMC12247394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.